| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventral Tegmental Area | 7 | 2025 | 49 | 3.770 |
Why?
|
| Porifera | 8 | 2026 | 16 | 3.190 |
Why?
|
| Cocaine | 9 | 2025 | 251 | 2.960 |
Why?
|
| Kidney Transplantation | 10 | 2026 | 101 | 2.680 |
Why?
|
| Neuroblastoma | 3 | 2022 | 136 | 1.040 |
Why?
|
| Potassium Channels | 2 | 2019 | 80 | 0.930 |
Why?
|
| Mycophenolic Acid | 3 | 2023 | 16 | 0.920 |
Why?
|
| Mesencephalon | 1 | 2025 | 49 | 0.920 |
Why?
|
| Diterpenes | 3 | 2026 | 97 | 0.910 |
Why?
|
| Animals | 33 | 2026 | 16992 | 0.900 |
Why?
|
| Sesterterpenes | 1 | 2024 | 1 | 0.890 |
Why?
|
| Cues | 1 | 2025 | 81 | 0.890 |
Why?
|
| Adenoviruses, Human | 1 | 2024 | 4 | 0.890 |
Why?
|
| Reward | 1 | 2025 | 112 | 0.860 |
Why?
|
| Siderophores | 6 | 2025 | 15 | 0.820 |
Why?
|
| Tetraodontiformes | 1 | 2023 | 4 | 0.810 |
Why?
|
| Nephrology | 1 | 2023 | 20 | 0.810 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2025 | 1766 | 0.780 |
Why?
|
| Antiviral Agents | 1 | 2024 | 195 | 0.750 |
Why?
|
| Agelas | 1 | 2022 | 1 | 0.750 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 241 | 0.710 |
Why?
|
| Phenazines | 1 | 2021 | 6 | 0.700 |
Why?
|
| Immunosuppressive Agents | 6 | 2026 | 94 | 0.700 |
Why?
|
| Photochemical Processes | 1 | 2021 | 19 | 0.700 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 75 | 0.690 |
Why?
|
| Actinobacteria | 1 | 2021 | 14 | 0.690 |
Why?
|
| Geologic Sediments | 1 | 2021 | 46 | 0.680 |
Why?
|
| Chromatin | 1 | 2022 | 186 | 0.680 |
Why?
|
| Urochordata | 1 | 2020 | 5 | 0.660 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 432 | 0.660 |
Why?
|
| Molecular Structure | 8 | 2025 | 570 | 0.650 |
Why?
|
| Protein Kinase C | 2 | 2018 | 124 | 0.640 |
Why?
|
| Marine Toxins | 1 | 2019 | 17 | 0.610 |
Why?
|
| Liver Transplantation | 4 | 2021 | 37 | 0.610 |
Why?
|
| Rats | 10 | 2025 | 3735 | 0.600 |
Why?
|
| Nitrogen | 3 | 2015 | 84 | 0.590 |
Why?
|
| Limbic System | 1 | 2019 | 31 | 0.580 |
Why?
|
| Receptors, AMPA | 1 | 2018 | 58 | 0.570 |
Why?
|
| Bivalvia | 3 | 2024 | 28 | 0.560 |
Why?
|
| Long-Term Potentiation | 1 | 2018 | 109 | 0.550 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 135 | 0.540 |
Why?
|
| Nucleus Accumbens | 1 | 2018 | 100 | 0.540 |
Why?
|
| Mexico | 5 | 2022 | 298 | 0.530 |
Why?
|
| Tacrolimus | 4 | 2026 | 16 | 0.520 |
Why?
|
| Bacteria | 1 | 2020 | 293 | 0.520 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 306 | 0.510 |
Why?
|
| Acclimatization | 2 | 2014 | 25 | 0.500 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2016 | 80 | 0.490 |
Why?
|
| Male | 20 | 2026 | 23409 | 0.480 |
Why?
|
| Graft Survival | 6 | 2026 | 47 | 0.480 |
Why?
|
| Tissue Donors | 4 | 2021 | 53 | 0.470 |
Why?
|
| Structure-Activity Relationship | 4 | 2024 | 506 | 0.470 |
Why?
|
| Colchicine | 1 | 2015 | 15 | 0.460 |
Why?
|
| Neural Inhibition | 2 | 2012 | 48 | 0.450 |
Why?
|
| Stilbenes | 1 | 2015 | 44 | 0.440 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2014 | 13 | 0.440 |
Why?
|
| Tubulin | 1 | 2015 | 96 | 0.440 |
Why?
|
| Photosynthesis | 1 | 2014 | 35 | 0.430 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 86 | 0.420 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 81 | 0.420 |
Why?
|
| Gene Expression | 2 | 2019 | 701 | 0.420 |
Why?
|
| Motor Activity | 4 | 2016 | 437 | 0.420 |
Why?
|
| Vibrio | 3 | 2024 | 19 | 0.400 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2021 | 301 | 0.390 |
Why?
|
| Ion Channels | 1 | 2012 | 74 | 0.380 |
Why?
|
| Anthozoa | 2 | 2010 | 23 | 0.370 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2012 | 5 | 0.370 |
Why?
|
| Humans | 31 | 2026 | 43102 | 0.370 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2012 | 39 | 0.360 |
Why?
|
| Cell Size | 1 | 2012 | 46 | 0.360 |
Why?
|
| Kidney Failure, Chronic | 2 | 2026 | 242 | 0.360 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2022 | 245 | 0.350 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1019 | 0.350 |
Why?
|
| Neuroprotective Agents | 2 | 2026 | 269 | 0.350 |
Why?
|
| Postoperative Complications | 3 | 2026 | 263 | 0.340 |
Why?
|
| Glutamic Acid | 1 | 2012 | 131 | 0.340 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2025 | 83 | 0.340 |
Why?
|
| Ascomycota | 2 | 2025 | 21 | 0.340 |
Why?
|
| Behavior, Animal | 3 | 2018 | 373 | 0.330 |
Why?
|
| Graft Rejection | 3 | 2026 | 43 | 0.320 |
Why?
|
| Tissue and Organ Procurement | 2 | 2021 | 54 | 0.310 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2019 | 157 | 0.300 |
Why?
|
| Shock | 2 | 2019 | 7 | 0.300 |
Why?
|
| Tetrodotoxin | 2 | 2023 | 22 | 0.300 |
Why?
|
| Cyclophilins | 2 | 2026 | 12 | 0.290 |
Why?
|
| Pyrrolidines | 1 | 2008 | 31 | 0.290 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 83 | 0.280 |
Why?
|
| Heart Arrest | 2 | 2018 | 52 | 0.280 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 88 | 0.280 |
Why?
|
| Retrospective Studies | 4 | 2023 | 2544 | 0.280 |
Why?
|
| Organ Preservation | 4 | 2021 | 5 | 0.270 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2006 | 29 | 0.250 |
Why?
|
| Eukaryota | 1 | 2006 | 20 | 0.250 |
Why?
|
| Phosphates | 1 | 2006 | 54 | 0.250 |
Why?
|
| Spain | 6 | 2023 | 44 | 0.240 |
Why?
|
| Brain | 2 | 2012 | 1472 | 0.240 |
Why?
|
| Nitrates | 1 | 2006 | 63 | 0.240 |
Why?
|
| Seasons | 1 | 2006 | 139 | 0.240 |
Why?
|
| Chromatography, Liquid | 2 | 2025 | 182 | 0.240 |
Why?
|
| Penicillium | 1 | 2025 | 6 | 0.230 |
Why?
|
| Cheese | 1 | 2025 | 4 | 0.230 |
Why?
|
| Reperfusion Injury | 1 | 2026 | 58 | 0.230 |
Why?
|
| Perfusion | 3 | 2021 | 38 | 0.230 |
Why?
|
| Electric Stimulation | 2 | 2016 | 186 | 0.230 |
Why?
|
| Self Administration | 1 | 2025 | 69 | 0.230 |
Why?
|
| Genomic Islands | 1 | 2024 | 16 | 0.220 |
Why?
|
| Photobacterium | 1 | 2024 | 7 | 0.220 |
Why?
|
| Lactams | 1 | 2024 | 10 | 0.220 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 2676 | 0.220 |
Why?
|
| Microglia | 1 | 2026 | 208 | 0.210 |
Why?
|
| Antilymphocyte Serum | 1 | 2023 | 4 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1124 | 0.200 |
Why?
|
| Prednisone | 1 | 2023 | 31 | 0.200 |
Why?
|
| El Salvador | 1 | 2023 | 3 | 0.200 |
Why?
|
| Waste Disposal, Fluid | 3 | 2008 | 19 | 0.200 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 458 | 0.200 |
Why?
|
| Spectrophotometry | 2 | 2021 | 63 | 0.200 |
Why?
|
| Organ Transplantation | 1 | 2023 | 24 | 0.190 |
Why?
|
| Patch-Clamp Techniques | 2 | 2014 | 228 | 0.190 |
Why?
|
| Distemper Virus, Canine | 1 | 2022 | 1 | 0.190 |
Why?
|
| Cell Survival | 3 | 2026 | 945 | 0.190 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2022 | 14 | 0.190 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2022 | 45 | 0.190 |
Why?
|
| Microsatellite Repeats | 1 | 2022 | 61 | 0.180 |
Why?
|
| alpha-Amylases | 2 | 2021 | 7 | 0.180 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 65 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 112 | 0.180 |
Why?
|
| RNA, Viral | 1 | 2023 | 321 | 0.180 |
Why?
|
| Genetics, Population | 1 | 2022 | 121 | 0.180 |
Why?
|
| Prazosin | 2 | 2014 | 9 | 0.170 |
Why?
|
| Passiflora | 1 | 2021 | 1 | 0.170 |
Why?
|
| Tablets, Enteric-Coated | 1 | 2021 | 2 | 0.170 |
Why?
|
| Electrophysiology | 1 | 2021 | 138 | 0.170 |
Why?
|
| Saponins | 1 | 2021 | 7 | 0.170 |
Why?
|
| Iron | 3 | 2025 | 251 | 0.170 |
Why?
|
| Kidney | 2 | 2022 | 372 | 0.170 |
Why?
|
| Triterpenes | 1 | 2021 | 18 | 0.170 |
Why?
|
| Quality of Life | 1 | 2026 | 616 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2014 | 388 | 0.160 |
Why?
|
| Pulmonary Medicine | 1 | 2020 | 3 | 0.160 |
Why?
|
| Wetlands | 1 | 2020 | 15 | 0.160 |
Why?
|
| Light | 1 | 2021 | 185 | 0.160 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 36 | 0.160 |
Why?
|
| Female | 11 | 2026 | 24698 | 0.160 |
Why?
|
| Time Factors | 3 | 2018 | 1857 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 26 | 0.160 |
Why?
|
| Regression Analysis | 1 | 2021 | 490 | 0.160 |
Why?
|
| Proteomics | 1 | 2022 | 378 | 0.160 |
Why?
|
| Carbon | 2 | 2014 | 128 | 0.160 |
Why?
|
| Action Potentials | 1 | 2021 | 246 | 0.150 |
Why?
|
| Donor Selection | 1 | 2019 | 9 | 0.150 |
Why?
|
| Clonidine | 2 | 2012 | 50 | 0.150 |
Why?
|
| Middle Aged | 7 | 2026 | 12222 | 0.150 |
Why?
|
| Caribbean Region | 1 | 2019 | 79 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 147 | 0.140 |
Why?
|
| Protein Subunits | 1 | 2019 | 93 | 0.140 |
Why?
|
| Plant Exudates | 1 | 2018 | 1 | 0.140 |
Why?
|
| Physalis | 1 | 2018 | 3 | 0.140 |
Why?
|
| Esters | 1 | 2018 | 25 | 0.140 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 235 | 0.140 |
Why?
|
| Sucrose | 1 | 2018 | 33 | 0.140 |
Why?
|
| Impulsive Behavior | 1 | 2018 | 55 | 0.140 |
Why?
|
| Withanolides | 1 | 2017 | 10 | 0.130 |
Why?
|
| Biophysics | 1 | 2016 | 38 | 0.130 |
Why?
|
| Child | 2 | 2022 | 3443 | 0.130 |
Why?
|
| Lichens | 1 | 2016 | 2 | 0.130 |
Why?
|
| Spinal Fractures | 1 | 2016 | 4 | 0.120 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2016 | 92 | 0.120 |
Why?
|
| Fruit | 1 | 2018 | 178 | 0.120 |
Why?
|
| Membrane Lipids | 1 | 2016 | 30 | 0.120 |
Why?
|
| Death | 3 | 2021 | 11 | 0.120 |
Why?
|
| Aortic Diseases | 1 | 2016 | 34 | 0.120 |
Why?
|
| Minerals | 1 | 2016 | 53 | 0.120 |
Why?
|
| Phospholipase D | 1 | 2016 | 49 | 0.120 |
Why?
|
| Drug Design | 1 | 2017 | 186 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 595 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 134 | 0.120 |
Why?
|
| Calcinosis | 1 | 2016 | 62 | 0.120 |
Why?
|
| Phenyl Ethers | 1 | 2015 | 4 | 0.110 |
Why?
|
| Pregnancy | 1 | 2021 | 1772 | 0.110 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2014 | 4 | 0.110 |
Why?
|
| Nitro Compounds | 1 | 2015 | 34 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 415 | 0.110 |
Why?
|
| Adrenergic Agents | 1 | 2014 | 8 | 0.110 |
Why?
|
| Oceans and Seas | 1 | 2014 | 18 | 0.110 |
Why?
|
| Benzophenanthridines | 1 | 2014 | 14 | 0.110 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 12 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 36 | 0.110 |
Why?
|
| Phenylephrine | 1 | 2014 | 34 | 0.110 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 35 | 0.110 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 19 | 0.110 |
Why?
|
| Electron Transport | 1 | 2014 | 47 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 196 | 0.110 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 54 | 0.110 |
Why?
|
| Mice | 4 | 2026 | 6644 | 0.110 |
Why?
|
| Particle Size | 1 | 2015 | 272 | 0.110 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 118 | 0.100 |
Why?
|
| Models, Molecular | 2 | 2015 | 876 | 0.100 |
Why?
|
| Species Specificity | 1 | 2014 | 286 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2015 | 346 | 0.100 |
Why?
|
| Aged | 6 | 2026 | 8214 | 0.100 |
Why?
|
| Binding Sites | 1 | 2015 | 671 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 159 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 518 | 0.100 |
Why?
|
| Ecosystem | 1 | 2014 | 175 | 0.100 |
Why?
|
| Multigene Family | 2 | 2025 | 105 | 0.100 |
Why?
|
| Indoles | 1 | 2014 | 187 | 0.100 |
Why?
|
| Risk Factors | 4 | 2026 | 3994 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1455 | 0.090 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2012 | 10 | 0.090 |
Why?
|
| Sex Factors | 1 | 2016 | 1028 | 0.090 |
Why?
|
| Excitatory Amino Acids | 1 | 2012 | 7 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2012 | 16 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2012 | 139 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 2 | 2026 | 147 | 0.090 |
Why?
|
| Sodium Channel Blockers | 1 | 2012 | 18 | 0.090 |
Why?
|
| Students | 1 | 2018 | 626 | 0.090 |
Why?
|
| Locomotion | 1 | 2012 | 105 | 0.090 |
Why?
|
| Genome, Bacterial | 2 | 2024 | 139 | 0.090 |
Why?
|
| Listonella | 1 | 2011 | 1 | 0.090 |
Why?
|
| Antarctic Regions | 2 | 2025 | 10 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2025 | 280 | 0.080 |
Why?
|
| Emulsions | 2 | 2008 | 36 | 0.080 |
Why?
|
| Depression | 1 | 2018 | 863 | 0.080 |
Why?
|
| Aluminum Compounds | 2 | 2007 | 10 | 0.080 |
Why?
|
| Cell Death | 2 | 2008 | 278 | 0.080 |
Why?
|
| Intestinal Fistula | 1 | 2010 | 4 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 14 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2026 | 1067 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2010 | 51 | 0.080 |
Why?
|
| Cyclosporine | 2 | 2022 | 36 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 486 | 0.080 |
Why?
|
| Apoptosis | 1 | 2017 | 1568 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2010 | 71 | 0.080 |
Why?
|
| Comorbidity | 2 | 2023 | 737 | 0.080 |
Why?
|
| Plant Leaves | 2 | 2021 | 136 | 0.070 |
Why?
|
| Biological Assay | 1 | 2008 | 63 | 0.070 |
Why?
|
| Environmental Monitoring | 1 | 2010 | 230 | 0.070 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2008 | 15 | 0.070 |
Why?
|
| Costa Rica | 2 | 2022 | 9 | 0.070 |
Why?
|
| Peptides | 1 | 2011 | 372 | 0.070 |
Why?
|
| Chemistry, Organic | 1 | 2007 | 6 | 0.070 |
Why?
|
| Steroids | 1 | 2007 | 45 | 0.060 |
Why?
|
| Idazoxan | 1 | 2006 | 10 | 0.060 |
Why?
|
| Nitrate Reductase | 1 | 2006 | 2 | 0.060 |
Why?
|
| Atlantic Ocean | 1 | 2006 | 2 | 0.060 |
Why?
|
| Yohimbine | 1 | 2006 | 24 | 0.060 |
Why?
|
| Carbonic Anhydrases | 1 | 2006 | 8 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2006 | 55 | 0.060 |
Why?
|
| Arctic Regions | 1 | 2006 | 21 | 0.060 |
Why?
|
| Chlorophyll | 1 | 2006 | 24 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 54 | 0.060 |
Why?
|
| Kidney Function Tests | 1 | 2026 | 32 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 263 | 0.060 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2026 | 90 | 0.060 |
Why?
|
| Age Factors | 2 | 2019 | 1154 | 0.060 |
Why?
|
| Acetylation | 1 | 2025 | 107 | 0.060 |
Why?
|
| Citrates | 1 | 2024 | 18 | 0.060 |
Why?
|
| Pyrrolidinones | 1 | 2024 | 11 | 0.060 |
Why?
|
| Chromosomes, Bacterial | 1 | 2024 | 21 | 0.060 |
Why?
|
| Mediterranean Sea | 1 | 2024 | 1 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2008 | 329 | 0.050 |
Why?
|
| Israel | 1 | 2024 | 21 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1604 | 0.050 |
Why?
|
| Mollusca | 1 | 2024 | 17 | 0.050 |
Why?
|
| Water Pollutants, Chemical | 1 | 2006 | 171 | 0.050 |
Why?
|
| Crustacea | 1 | 2024 | 23 | 0.050 |
Why?
|
| Prognosis | 1 | 2026 | 861 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 532 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 38 | 0.050 |
Why?
|
| Animals, Wild | 1 | 2022 | 24 | 0.050 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2002 | 18 | 0.050 |
Why?
|
| Cyclophilin A | 1 | 2022 | 19 | 0.050 |
Why?
|
| Narcotics | 1 | 2002 | 29 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2022 | 51 | 0.050 |
Why?
|
| Living Donors | 1 | 2022 | 18 | 0.050 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2022 | 34 | 0.050 |
Why?
|
| Cell Line | 1 | 2026 | 1410 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2002 | 55 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 80 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 234 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2022 | 206 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2026 | 1600 | 0.040 |
Why?
|
| Testosterone | 1 | 2002 | 211 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 175 | 0.040 |
Why?
|
| Virulence | 1 | 2021 | 246 | 0.040 |
Why?
|
| Estrogens | 1 | 2002 | 203 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 260 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 167 | 0.040 |
Why?
|
| Seawater | 1 | 2020 | 54 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 32 | 0.040 |
Why?
|
| Dyspnea | 1 | 2020 | 22 | 0.040 |
Why?
|
| Metabolomics | 1 | 2021 | 95 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2002 | 258 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 44 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 72 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2026 | 1003 | 0.040 |
Why?
|
| Wnt1 Protein | 1 | 2019 | 2 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 355 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 1621 | 0.040 |
Why?
|
| Medical Futility | 1 | 2019 | 10 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1596 | 0.040 |
Why?
|
| Delayed Graft Function | 1 | 2018 | 2 | 0.040 |
Why?
|
| Cold Ischemia | 1 | 2018 | 3 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 63 | 0.040 |
Why?
|
| Cadaver | 1 | 2018 | 40 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 83 | 0.040 |
Why?
|
| Asthma | 1 | 2023 | 416 | 0.040 |
Why?
|
| Propensity Score | 1 | 2018 | 59 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 90 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 3156 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 355 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2018 | 62 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 408 | 0.030 |
Why?
|
| Kinetics | 2 | 2011 | 695 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 186 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 161 | 0.030 |
Why?
|
| Withania | 1 | 2017 | 6 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2021 | 302 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 456 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1271 | 0.030 |
Why?
|
| Vero Cells | 1 | 2017 | 112 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 5080 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 299 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 6081 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 437 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 282 | 0.030 |
Why?
|
| Self Concept | 1 | 2018 | 171 | 0.030 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2016 | 14 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2016 | 22 | 0.030 |
Why?
|
| Dehydration | 1 | 2016 | 23 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2016 | 17 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 41 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 561 | 0.030 |
Why?
|
| Albuminuria | 1 | 2016 | 78 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 1177 | 0.030 |
Why?
|
| Adult | 3 | 2018 | 13872 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 143 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1009 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 1263 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 107 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 84 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 206 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2019 | 735 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1546 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2015 | 169 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 968 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 1612 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 986 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2853 | 0.020 |
Why?
|
| Potentiometry | 1 | 2011 | 8 | 0.020 |
Why?
|
| Fish Diseases | 1 | 2011 | 8 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 71 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2011 | 62 | 0.020 |
Why?
|
| Pacific Ocean | 1 | 2010 | 13 | 0.020 |
Why?
|
| Population Density | 1 | 2010 | 38 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 204 | 0.020 |
Why?
|
| Oils | 1 | 2008 | 6 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 518 | 0.020 |
Why?
|
| HIV-1 | 1 | 2014 | 755 | 0.020 |
Why?
|
| Aluminum | 1 | 2008 | 39 | 0.020 |
Why?
|
| Uridine Triphosphate | 1 | 2008 | 7 | 0.020 |
Why?
|
| Fura-2 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2008 | 19 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2008 | 21 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2008 | 29 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 509 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2007 | 38 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 97 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 760 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 152 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 112 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 184 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 99 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 206 | 0.020 |
Why?
|
| Industrial Waste | 1 | 2006 | 16 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 182 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 498 | 0.020 |
Why?
|
| Water | 1 | 2008 | 316 | 0.010 |
Why?
|
| Temperature | 1 | 2006 | 313 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 491 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 2002 | 10 | 0.010 |
Why?
|
| Pilocarpine | 1 | 2002 | 8 | 0.010 |
Why?
|
| Kainic Acid | 1 | 2002 | 48 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2002 | 43 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2002 | 23 | 0.010 |
Why?
|
| Naloxone | 1 | 2002 | 56 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2002 | 127 | 0.010 |
Why?
|
| Corticosterone | 1 | 2002 | 90 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 150 | 0.010 |
Why?
|
| Reaction Time | 1 | 2002 | 157 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 268 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 734 | 0.010 |
Why?
|